Michael W. Laird

1.4k total citations
43 papers, 1.1k citations indexed

About

Michael W. Laird is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Michael W. Laird has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Genetics. Recurrent topics in Michael W. Laird's work include Viral Infectious Diseases and Gene Expression in Insects (26 papers), Protein purification and stability (19 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Michael W. Laird is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (26 papers), Protein purification and stability (19 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Michael W. Laird collaborates with scholars based in United States, United Kingdom and Switzerland. Michael W. Laird's co-authors include John C. Joly, Yung‐Hsiang Kao, Amy Shen, Brad Snedecor, Thomas J. Silhavy, Tracy Raivio, Karthik Veeravalli, Daniel Hewitt, David Shaw and Róbert Kiss and has published in prestigious journals such as Biochemistry, The Journal of Infectious Diseases and Molecular Microbiology.

In The Last Decade

Michael W. Laird

41 papers receiving 1.0k citations

Peers

Michael W. Laird

RNMI

GENET

BIOTE

ONCOL

Marc Vanhove Belgium

Shengshu Huang United States

Elizabeth Boeggeman United States

Yao‐Yun Fan Switzerland

Antoni Benito Spain

Karin Welfle Germany

Andreas Christmann Germany

Doreen A. Wüstenhagen Germany

Fana B. Mersha United States

Christian Lizak Switzerland

Marc Vanhove Belgium

Michael W. Laird

629 ×0.7

204 ×0.5

RNMI

153 ×0.6

GENET

78 ×0.6

BIOTE

99 ×1.1

ONCOL

Citations per year, relative to Michael W. Laird Michael W. Laird (= 1×) peers Marc Vanhove

Countries citing papers authored by Michael W. Laird

Since Specialization

Citations

This map shows the geographic impact of Michael W. Laird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Laird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Laird more than expected).

Fields of papers citing papers by Michael W. Laird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Laird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Laird. The network helps show where Michael W. Laird may publish in the future.

Co-authorship network of co-authors of Michael W. Laird

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Laird. A scholar is included among the top collaborators of Michael W. Laird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Laird. Michael W. Laird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barnard, Gavin C., Michelle Zhou, Amy Shen, Inn H. Yuk, & Michael W. Laird. (2023). Utilizing targeted integration CHO pools to potentially accelerate the GMP manufacturing of monoclonal and bispecific antibodies. Biotechnology Progress. 40(1). e3399–e3399. 5 indexed citations

Veeravalli, Karthik, Rebekah McKenna, Christopher J.M. Williams, et al.. (2022). Enzymatic basis of the Fc-selective intra-chain disulfide reduction and free thiol content variability in an antibody produced in Escherichia coli. Microbial Cell Factories. 21(1). 167–167.

Tang, Danming, et al.. (2021). Bax and Bak knockout apoptosis‐resistant Chinese hamster ovary cell lines significantly improve culture viability and titer in intensified fed‐batch culture process. Biotechnology Progress. 38(2). e3228–e3228. 14 indexed citations

Wu, Paul Y K, Louise Almond, Jennitte Stevens, et al.. (2019). Advancing Biologics Development Programs with Legacy Cell Lines: Advantages and Limitations of Genetic Testing for Addressing Clonality Concerns Prior to Availability of Late Stage Process and Product Consistency Data. PDA Journal of Pharmaceutical Science and Technology. 74(2). 264–274. 2 indexed citations

Kelley, Brian D., Róbert Kiss, & Michael W. Laird. (2018). A Different Perspective: How Much Innovation Is Really Needed for Monoclonal Antibody Production Using Mammalian Cell Technology?. Advances in biochemical engineering, biotechnology. 165. 443–462. 37 indexed citations

Hu, Zhilan, Danming Tang, Shahram Misaghi, et al.. (2017). Evaluation of heavy chain C‐terminal deletions on productivity and product quality of monoclonal antibodies in Chinese hamster ovary (CHO) cells. Biotechnology Progress. 33(3). 786–794. 14 indexed citations

Veeravalli, Karthik, et al.. (2017). Strain engineering to reduce acetate accumulation during microaerobic growth conditions in Escherichia coli. Biotechnology Progress. 34(2). 303–314. 14 indexed citations

Veeravalli, Karthik & Michael W. Laird. (2015). Toward an era of utilizing methionine overproducing hosts for recombinant protein production inEscherichia coli. Bioengineered. 6(3). 132–135. 3 indexed citations

Gao, Xuan, Junyan A. Ji, Karthik Veeravalli, et al.. (2014). Effect of Individual Fc Methionine Oxidation on FcRn Binding: Met252 Oxidation Impairs FcRn Binding More Profoundly than Met428 Oxidation. Journal of Pharmaceutical Sciences. 104(2). 368–377. 89 indexed citations

10.

Kao, Yung‐Hsiang, et al.. (2010). Mechanism of antibody reduction in cell culture production processes. Biotechnology and Bioengineering. 107(4). 622–632. 54 indexed citations

11.

Laird, Michael W., et al.. (2010). Characterization of a Monoclonal Antibody Cell Culture Production Process Using a Quality by Design Approach. Molecular Biotechnology. 45(3). 203–206. 40 indexed citations

12.

Guo, Donglin, Albert Gao, David A. Michels, et al.. (2010). Mechanisms of unintended amino acid sequence changes in recombinant monoclonal antibodies expressed in Chinese Hamster Ovary (CHO) cells. Biotechnology and Bioengineering. 107(1). 163–171. 57 indexed citations

13.

Pizarro, Shelly A., Matt Field, Michael Lee, et al.. (2010). High-yield expression of human vascular endothelial growth factor VEGF165 in Escherichia coli and purification for therapeutic applications. Protein Expression and Purification. 72(2). 184–193. 24 indexed citations

14.

Li, Yan, Xizhong Cui, Xuemei Li, et al.. (2007). Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model*. Critical Care Medicine. 35(6). 1560–1567. 18 indexed citations

15.

Cui, Xizhong, Yan Li, Xuemei Li, et al.. (2007). Bacillus anthracisEdema and Lethal Toxin Have Different Hemodynamic Effects but Function Together to Worsen Shock and Outcome in a Rat Model. The Journal of Infectious Diseases. 195(4). 572–580. 50 indexed citations

16.

Zhang, Linyi, et al.. (2005). Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen. Journal of Immunological Methods. 298(1-2). 47–60. 7 indexed citations

17.

Laird, Michael W., et al.. (2004). Keratinocyte Growth Factor-2 Production in an ompT-Deficient Escherichia coli K-12 Mutant. Biotechnology Progress. 20(1). 44–50. 5 indexed citations

18.

Sampey, Gavin C., et al.. (2004). Production of Biologically Active Bacillus anthracis Edema Factor in Escherichia coli. Biotechnology Progress. 20(6). 1651–1659. 16 indexed citations

19.

Laird, Michael W., et al.. (2004). Optimization of BLyS production and purification from Escherichia coli. Protein Expression and Purification. 39(2). 237–246. 12 indexed citations

20.

Laird, Michael W., Kelly E. Johnson, Gavin C. Sampey, et al.. (2004). Production and purification of Bacillus anthracis protective antigen from Escherichia coli. Protein Expression and Purification. 38(1). 145–152. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact